Tag archive for ‘Eli Lilly and Company’
Natco Pharma signs licensing deal with Lilly for Covid drug Baricitinib
By businessnewstoday On Tuesday, May 18th, 2021
0 Comments

Natco Pharma signs licensing deal with Lilly for Covid drug Baricitinib

Natco Pharma has signed a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company (Lilly) for manufacturing and commercializing Baricitinib for the treatment of Covid-19 in India. With More...

Torrent Pharma signs licensing deal with Lilly for Covid drug baricitinib
By businessnewstoday On Friday, May 14th, 2021
0 Comments

Torrent Pharma signs licensing deal with Lilly for Covid drug baricitinib

Torrent Pharmaceuticals (Torrent Pharma) has signed a licensing agreement with Eli Lilly and Company with an objective to bring the latter’s baricitinib for Covid-19 treatment in India. The royalty free, non-exclusive More...

Dr. Reddy’s Laboratories, Lilly sign deal for Covid-19 drug baricitinib
By businessnewstoday On Wednesday, May 12th, 2021
0 Comments

Dr. Reddy’s Laboratories, Lilly sign deal for Covid-19 drug baricitinib

Dr. Reddy’s Laboratories said that it has forged a royalty-free, non-exclusive voluntary licensing agreement with US pharma giant Eli Lilly and Company (Lilly) for the manufacturing and commercialization of Covid-19 More...

Sun Pharma signs licensing deal with Lilly for Covid-19 drug baricitinib
By businessnewstoday On Monday, May 10th, 2021
0 Comments

Sun Pharma signs licensing deal with Lilly for Covid-19 drug baricitinib

Sun Pharmaceutical Industries (Sun Pharma) said that it has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for expanding access to the latter’s baricitinib in India. The More...

Lupin strikes deal with Lilly for Covid-19 drug Baricitinib in India
By businessnewstoday On Monday, May 10th, 2021
0 Comments

Lupin strikes deal with Lilly for Covid-19 drug Baricitinib in India

Lupin Limited said that it has signed a royalty-free, limited, non-exclusive voluntary licensing agreement with Eli Lilly and Company (Lilly) for manufacturing and selling the latter’s Baricitinib in India. Baricitinib More...

Natco Pharma gets CDSCO nod for use of Baricitinib in Covid patients
By businessnewstoday On Monday, May 3rd, 2021
0 Comments

Natco Pharma gets CDSCO nod for use of Baricitinib in Covid patients

Natco Pharma has secured emergency use approval for Baricitinib from India’s Central Drugs Standard Control Organization (CDSCO) for the treatment of Covid-19. The Indian pharma company has been given the nod More...

By pharmanewsdaily On Saturday, January 23rd, 2021
0 Comments

Lilly wraps up acquisition of gene therapy company Prevail Therapeutics

Eli Lilly and Company (Lilly) has completed its previously announced deal worth up to $1.04 billion of US gene therapy company Prevail Therapeutics. The US pharma giant said that the deal gives it a new modality More...

By pharmanewsdaily On Saturday, December 19th, 2020
0 Comments

Lilly to launch pragmatic study of Covid-19 drug candidate bamlanivimab in New Mexico

Eli Lilly and Company (Lilly) has revealed plans to launch a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with Covid-19, in partnership with major local institutions in New Mexico. The US More...

By pharmanewsdaily On Wednesday, December 16th, 2020
0 Comments

Lilly to acquire US gene therapy company Prevail Therapeutics in $1bn deal

Eli Lilly and Company (Lilly) has signed a deal worth up to $1.04 billion to acquire Prevail Therapeutics, a US gene therapy company engaged in developing disease-modifying AAV9-based gene therapies for neurodegenerative More...

By pharmanewsdaily On Sunday, December 6th, 2020
0 Comments

Bamlanivimab Covid-19 drug candidate : Lilly, UnitedHealth Group join forces for pragmatic study

Eli Lilly and Company (Lilly) has entered into a partnership with managed care company UnitedHealth Group to carry out a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, Covid-19 infected individuals. Recently, More...